
Department of Veterans Affairs looks to end certain abortion services for veterans
In a proposed rule filed Friday, the department said that it is seeking to revoke access to abortions and abortion counseling for veterans and the beneficiaries of the Civilian Health and Medical Program of the Department of Veterans Affairs.
'We take this action to ensure that VA provides only needed medical services to our nation's heroes and their families,' the department said in the filing.
Under the Biden administration's rule, the department currently provides access to abortions when a pregnant veteran's life or health is at risk if their pregnancy were carried to term, or if the pregnancy was the result of rape or incest — regardless of state laws.
The proposed rule would allow abortions in cases where 'a physician certifies that the life of the mother would be endangered if the fetus were carried to term,' which, according to the filing, had been permitted even before the 2022 expansion.
The Biden-era rule was part of the administration's efforts to expand abortion access after Republican-led states pushed ahead with restrictions in the wake of the 2022 Supreme Court ruling that eliminated the federal right to an abortion.
The VA argued at the time that it was necessary to give veterans access to abortions, saying, 'As abortion bans come into force across the country, veterans in many States are no longer assured access to abortion services in their communities, even when those services are needed.'
But on Friday, President Donald Trump's VA slammed the Biden administration's rule, calling it federal overreach.
'The stated reason for (the expansion) was a reaction to a Supreme Court decision, Dobbs v. Jackson Women's Health Organization … that itself was intended to prevent federal overreach and return to States control over the provision of abortion services,' the filing states. 'Yet, the last administration used Dobbs to do the exact opposite of preventing overreach, creating a purported Federal entitlement to abortion for veterans where none had existed before and without regard to State law.'
Twenty states have banned or limited access to abortion. States where abortion is limited report higher rates of maternal and infant mortality, as well as greater economic insecurity.
The proposed rule will now be open for public comment for 30 days starting Monday.
In his first term, Trump made good on campaign promises and appointed Supreme Court justices who helped overturn Roe v. Wade. Since that ruling, Trump has been keen to leave regulations over the issue to state governments.
The Trump administration has overall been quiet on the issue of abortion in his second term. However, in June, the US Department of Health and Human Services and the Centers for Medicare & Medicaid Services moved to rescind a 2022 federal guidance to health care providers specifying that people should be able to access an abortion in the event of a medical emergency, even if state laws restrict such procedures.
CNN's Veronica Stracqualursi and Jen Christensen contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Politico
16 minutes ago
- Politico
Texas Dems to flee state amid national redistricting battle
They will head to Illinois, where Gov. JB Pritzker has expressed sympathy for their plight. A map of Congressional Districts proposed plan is seen a Texas legislators' public hearing on redistricting in Austin on Aug. 1, 2025. | Eric Gay/AP By Adam Wren 08/03/2025 03:57 PM EDT Dozens of Texas Democrats plan to flee the state amid a special session Sunday afternoon, making a last-ditch effort to disrupt a mid-decade redistricting attempt forced by President Donald Trump, according to one person briefed on the matter. It marks their second act of breaking quorum — when the state House will lack the minimum number of lawmakers needed to conduct business — since 2021. And it comes as the party scrambles to counter the aggressive action in Texas, intended to keep Republicans in power in Congress next year by creating five GOP-friendly seats in the state. Four years ago, Republican Texas Gov. Greg Abbott called for the arrest of fleeing lawmakers upon their return to their state.
Yahoo
43 minutes ago
- Yahoo
Where is Epstein's island? Trump said he ‘never had the privilege' to visit
President Donald Trump denied ever visiting late sex offender Jeffrey Epstein's private island in one of his "very good moments." Trump was in Scotland answering questions from reporters on July 28 as the controversy over the criminal case files on the financier indicted on sex trafficking charges continues to roil his administration. Epstein owned a small private island in the U.S. Virgin Islands, where sex trafficking of young girls allegedly occurred. 'I never had the privilege of going to his island, and I did turn it down, but a lot of people in Palm Beach were invited to his island," Trump said. 'In one of my very good moments, I turned it down. I didn't want to go to his island.' Where does the island fit in the Epstein saga? Here is what to know: More: Trump says poached Mar-a-Lago spa staff included Epstein accuser Virginia Giuffre What happened at Epstein's island? In January 2020, prosecutors with the U.S. Virgin Islands filed a lawsuit against Epstein's estate, alleging a criminal enterprise took place on his property there involving the sexual abuse of young girls. "Epstein owned and arranged for private planes, helicopters, boat and automobiles to transport victims to, from and within the Virgin Islands, and provided money to pay these young women and underage girls," the lawsuit stated. Numerous girls forced into his scheme were 12 to 17 years old, the lawsuit alleged, stating local authorities last observed related events happening in 2018. A web of companies owned by Epstein, dubbed the "Epstein Enterprise" by prosecutors, "deceptively lured underage girls and women into its sex trafficking ring with money and promises of employment, career opportunities and school assistance." One 15-year-old girl tried to escape by swimming, the lawsuit states. The estate settled the case with the U.S. Virgin Islands for $105 million in December 2022. More: Jeffrey Epstein, a survivor's untold story and the complexity of abuse Where is the Epstein island located? The island Epstein owned was in the U.S Virgin Islands. Epstein also owned property in New York and Palm Beach, where federal U.S. prosecutors also allege sex trafficking occurred. Ghislaine Maxwell eyes clemency as MAGA calls for Epstein transparency Trump has been dealing with questions and controversy over Epstein for weeks, with members of both parties calling for more transparency about the man's criminal case. Trump has called for the release of more documents, but one federal judge in Florida has already denied the request to unseal grand jury transcripts. The backlash has also led the Department of Justice back to Epstein's ex-partner Ghislaine Maxwell for more information. She is serving a 20-year prison sentence for trafficking a minor to Epstein for sexual abuse. She spoke with DOJ officials over two days last week, and Trump has not yet ruled out a pardon. Trump and Epstein shared a friendship for years, as they were both part of the Palm Beach, Florida, community, where Mar-a-Lago is located. 'I wouldn't talk to Jeffrey Epstein because he did something that was inappropriate. … He stole people that worked for me. I said, 'Don't ever do that again.' He did it again, and I threw him out of the place,' Trump said, in reference to his Mar-a-Lago club and residence. 'Persona non grata." Contributing: Josh Meyer and Aysha Bagchi, USA TODAY Kinsey Crowley is the Trump Connect reporter for the USA TODAY Network. Reach her at kcrowley@ Follow her on X and TikTok @kinseycrowley or Bluesky at @ This article originally appeared on USA TODAY: Trump said he 'never had the privilege' to visit island Epstein owned Solve the daily Crossword
Yahoo
43 minutes ago
- Yahoo
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
Key Points Hims & Hers Health is unlocking new sources of growth potential, and its balance sheet is flourishing. Doximity is a prime platform for advertisers, and the profits are pouring in. 10 stocks we like better than Hims & Hers Health › It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the industries and sectors you gravitate toward, the amount of capital you have to invest, and your own personal risk tolerance. If you have cash to invest in the stock market right now, and you're looking for growth stocks that could make smart additions to the basket of businesses you own, there are names to be found across a range of industries, including healthcare. Here are two healthcare stocks that have at least doubled over the past 12 months but still look poised to deliver favorable returns for shareholders in the next three to five years. 1. Hims & Hers Health Hims & Hers Health (NYSE: HIMS) has witnessed a stock run-up of more than 200% over the trailing-12-month period. In contrast, the S&P 500 is up only about 18% in that same time frame. This boom in the company's share price has occurred for a few reasons. Investors were particularly excited about the company's ability to offer affordable, compounded GLP-1 drugs for weight loss amid shortages of branded versions, and that fueled significant revenue growth and share-price appreciation. However, Hims & Hers can no longer mass-produce compounded drugs like semaglutide because the U.S. Food and Drug Administration declared the shortage resolved. While the company may still offer personalized doses where clinically applicable, its primary weight loss offerings are shifting to oral medications and liraglutide. In fact, Novo Nordisk, the maker of Wegovy (semaglutide for weight) and Ozempic (semaglutide for diabetes), ended its partnership with Hims & Hers, citing concerns over the latter company's promotion and sales of compounded semaglutide. While the company's offerings may evolve in the coming months and years, it has other sources of growth to lean on besides the weight loss segment. Hims & Hers' areas of focus include sexual health, hair loss, dermatology, mental health, and primary care. The platform also provides access to both over-the-counter and prescription treatments via online consultations with licensed healthcare professionals, and most of its revenue still comes from recurring subscriptions paid by healthcare consumers. The recent acquisition of Zava, a European digital health platform, seems to have boosted investor confidence in the future of the business outside of its ambitions in the weight loss industry. The addition of Zava to Hims & Hers' ecosystem will expand its reach into the U.K., Ireland, France, and Germany. Hims & Hers also plans to launch its platform in Canada in 2026. Revenue grew by 110% year over year in the first quarter, and the company is building upon an improving track record of profitability. Hims & Hers also delivered free cash flow of about $50 million in Q1. This business has a lot of potential. 2. Doximity Doximity (NYSE: DOCS) has seen shares pop by a bit more than 100% since this time one year ago. Doximity is known as the largest digital platform for U.S. medical professionals. It serves as a professional and social network for healthcare professionals including doctors, nurse practitioners, and physician assistants, and offers a wide variety of tools for communication, news, and career management. Doximity provides a curated newsfeed with the latest medical news and research relevant to different specialties, and also offers tools for job searches, salary comparisons, and reputation management. The platform even provides telehealth solutions, enabling virtual patient visits and consultations. The platform is free for healthcare professionals to use. This free access includes Doximity Dialer, a feature that allows secure communication with patients using a customized calling tool. The platform also offers free digital fax lines and access to Doximity Scribe, an AI-powered note-taking tool for verified clinicians. So, how does Doximity make money? From advertising and selling information. Doximity's platform is a prime digital marketing and advertising tool for pharmaceutical manufacturers and healthcare systems (like hospitals). These entities pay Doximity to advertise and promote their products and services to targeted medical professionals. Health systems and medical recruiting firms also pay Doximity to access its database of medical professionals for recruitment and hiring purposes. In Doximity's fiscal 2025, which ended March 31, revenue increased 20% from the prior fiscal year to $570.4 million. The company reported net income of $223.2 million, up 51% year over year, with free cash flow spiking 50% to $266.7 million. This healthcare stock is really an advertising business at its core, and a profitable one at that. These factors could induce some investors to take another long look at this top stock and I think it has room to run. Do the experts think Hims & Hers Health is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Hims & Hers Health make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Doximity and Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤